NCT02105493View on ClinicalTrials.gov

Nitroglycerin Prevents Radial Artery Occlusion

NACompletedINTERVENTIONAL
Enrollment

1,706

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

March 31, 2014

Conditions
Injury of Radial Artery
Interventions
DRUG

500 microgram of Nitroglycerin

500 microgram of Nitroglycerin (in 5 mL saline) given intra-arterially through the sheath at the end of transradial procedure

DRUG

Saline 5 mL

Saline 5 mL given intra-arterially through the sheath at the end of transradial procedure

Trial Locations (1)

11420

National Cardiovascular Center Harapan Kita, Jakarta

All Listed Sponsors
lead

National Cardiovascular Center Harapan Kita Hospital Indonesia

OTHER

NCT02105493 - Nitroglycerin Prevents Radial Artery Occlusion | Biotech Hunter | Biotech Hunter